Stockreport

Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

Apollomics Inc. - Class A Ordinary Shares  (APLM) 
PDF FOSTER CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company [Read more]